Azithromycin vs placebo | No demonstrated result | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
---|
Acute coronary syndrome | 0.97 [0.85 1.10] | p=1.00 | 0 | 12338 | 5 | Gupta et al,ACADEMIC,WIZARD,ACES,STAMINA (Azithromycin), | cardiovascular events | no data | myocardial infarction (fatal and non fatal) | 0.97 [0.82 1.14] | p=1.00 | 0 | 13475 | 4 | ACADEMIC,WIZARD,ACES,AZACS, | Coronary event | no data | All cause death | 1.01 [0.88 1.15] | p=1.00 | 0 | 13754 | 6 | Gupta et al,ACADEMIC,WIZARD,ACES,STAMINA (Azithromycin),AZACS, | TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |